BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29112487)

  • 1. Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review.
    Lawlor CM; Ananth A; Barton BM; Flowers TC; McCoul ED
    Otolaryngol Head Neck Surg; 2018 Feb; 158(2):232-239. PubMed ID: 29112487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
    Culley CM; DiBridge JN; Wilson GL
    Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.
    Scalese MJ; Reinaker TS
    Am J Health Syst Pharm; 2016 Jun; 73(12):873-9. PubMed ID: 27261237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
    Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
    J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibitor-induced angioedema.
    Baram M; Kommuri A; Sellers SA; Cohn JR
    J Allergy Clin Immunol Pract; 2013; 1(5):442-5. PubMed ID: 24565614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence.
    Riha HM; Summers BB; Rivera JV; Van Berkel MA
    J Emerg Med; 2017 Nov; 53(5):662-679. PubMed ID: 28939396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ACEI-related angioedema with icatibant: a case series.
    Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A
    Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
    Baş M; Greve J; Stelter K; Havel M; Strassen U; Rotter N; Veit J; Schossow B; Hapfelmeier A; Kehl V; Kojda G; Hoffmann TK
    N Engl J Med; 2015 Jan; 372(5):418-25. PubMed ID: 25629740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
    Fok JS; Katelaris CH; Brown AF; Smith WB
    Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitor-mediated angioedema.
    Montinaro V; Cicardi M
    Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Life-Threatening ACE-Inhibitor-Induced Angioedema.
    Hirschy R; Shah T; Davis T; Rech MA
    Adv Emerg Nurs J; 2018; 40(4):267-277. PubMed ID: 30365440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
    Jeon J; Lee YJ; Lee SY
    J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
    Bartal C; Zeldetz V; Stavi V; Barski L
    Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
    Fast S; Henningsen E; Bygum A
    Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
    Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
    Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema.
    Hassen GW; Kalantari H; Parraga M; Chirurgi R; Meletiche C; Chan C; Ciarlo J; Gazi F; Lobaito C; Tadayon S; Yemane S; Velez C
    J Emerg Med; 2013 Apr; 44(4):764-72. PubMed ID: 23114109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department management of patients with ACE-inhibitor angioedema.
    Winters ME; Rosenbaum S; Vilke GM; Almazroua FY
    J Emerg Med; 2013 Nov; 45(5):775-80. PubMed ID: 23988141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icatibant Compared to Steroids and Antihistamines for ACE-Inhibitor-Induced Angioedema.
    Botnaru T; Robert A; Mottillo S
    CJEM; 2017 Mar; 19(2):159-162. PubMed ID: 27189625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.
    Sinert R; Levy P; Bernstein JA; Body R; Sivilotti MLA; Moellman J; Schranz J; Baptista J; Kimura A; Nothaft W;
    J Allergy Clin Immunol Pract; 2017; 5(5):1402-1409.e3. PubMed ID: 28552382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The ulm emergency algorithm for the acute treatment of drug-induced, bradykinin-mediated angioedema].
    Hahn J; Bock B; Muth CM; Pfaue A; Friedrich D; Hoffmann TK; Greve J
    Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):708-716. PubMed ID: 30232503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.